10 International Dividend Aristocrats With Exceptional Dividend Growth Histories – Sure Dividend

Up to date on Could twenty eighth, 2026 by Bob Ciura

There are good causes for buyers to personal worldwide shares, akin to diversification. Many corporations that function outdoors the U.S. have entry to geographic markets that would outperform the U.S. within the occasion of a home financial downturn.

In fact, there are dangers to buying worldwide shares, akin to foreign money danger.

Nonetheless, revenue buyers searching for high quality dividend shares mustn’t at all times ignore worldwide shares. Certainly, there are numerous high quality worldwide shares which have compiled spectacular dividend progress histories.

Earnings buyers are possible accustomed to the Dividend Aristocrats, that are a few of the highest-quality shares to purchase and maintain for the long run.

You possibly can obtain the complete Dividend Aristocrats record, together with essential metrics like dividend yields and price-to-earnings ratios, by clicking on the hyperlink under:

 

Disclaimer: Positive Dividend isn’t affiliated with S&P International in any approach. S&P International owns and maintains The Dividend Aristocrats Index. The knowledge on this article and downloadable spreadsheet relies on Positive Dividend’s personal overview, abstract, and evaluation of the S&P 500 Dividend Aristocrats ETF (NOBL) and different sources, and is supposed to assist particular person buyers higher perceive this ETF and the index upon which it’s primarily based. Not one of the info on this article or spreadsheet is official information from S&P International. Seek the advice of S&P International for official info.

The record of Dividend Aristocrats is diversified throughout a number of sectors, together with shopper items, financials, industrials, and healthcare.

However it isn’t diversified geographically to incorporate worldwide shares.

With this in thoughts, this text will focus on 10 worldwide dividend progress shares which have raised their dividends for over 25 consecutive years, of their residence currencies.

Desk of Contents

The desk of contents under permits for simple navigation. The shares are listed by 5-year annual anticipated returns, in ascending order.

Worldwide Dividend Aristocrat #10: Unilever plc (UL)

• Consecutive Years Of Dividend Will increase: 43
• Annual Anticipated Returns: 10.2%

Unilever is among the largest shopper items corporations on the earth, producing and advertising ~400 manufacturers in practically 200 nations.

Effectively-known manufacturers embrace Ben & Jerry’s, Q-tips, Vaseline, Axe, Dove, Hellmann’s, Knorr and plenty of extra. Its merchandise are utilized by greater than 3 billion folks daily.

In mid-February, Unilever reported (2/12/26) monetary outcomes for the complete fiscal 2025. It grew its underlying gross sales 3.5% over the prior 12 months because of 2.0% value hikes and 1.5% quantity progress.

The 30 strongest manufacturers grew their gross sales 4.3% and comprised 78% of whole gross sales. The sturdy manufacturers of the corporate have enabled it to boost costs aggressively with no vital impact on quantity within the final 4 years.

Nevertheless, as customers have change into extra price-sensitive, value hikes have moderated in latest quarters.

Unilever offered steerage for gross sales progress of 4%-6% in 2026, with at the least 2.0% underlying quantity progress and a modest enchancment in working margin (vs. 20.0% in 2025), according to its long-term steerage.

Unilever has a major aggressive benefit, particularly the power of its manufacturers. The corporate generates ~80% of its gross sales from the #1 or #2 place in its markets.

Because of this, Unilever has been capable of increase its dividend for 43 consecutive years in Euros.

Click on right here to obtain our most up-to-date Positive Evaluation report on UL (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #9: RenaissanceRe Holdings Ltd. (RNR)

• Consecutive Years Of Dividend Will increase: 31
• Annual Anticipated Returns: 10.3%

RenaissanceRe Holdings Ltd. is a worldwide supplier of reinsurance and insurance coverage.

The corporate supplies property, casualty and specialty reinsurance by RenaissanceRe together with joint ventures together with DaVinci, Prime Layer Re, Starbound, Glencoe Group and Starbound II.

Roughly half of premiums earned are attributable to property insurance policies, with the rest allotted to casualty and specialty.

On April twenty eighth, 2026, RenaissanceRe introduced its Q1 outcomes for the interval ending March thirty first, 2026. Whole income for the quarter was $2.19 billion, down from $3.47 billion in Q1-2025, pushed primarily by web realized and unrealized funding losses as market yields elevated and fairness markets declined in the course of the quarter.

For the quarter, working revenue was $590.5 million, or $13.75 per share, in comparison with an working lack of $69.8 million, or $(1.49) per share, in Q1-2025.

Internet revenue out there to frequent shareholders totaled $284.5 million, or $6.57 per share, versus $161.1 million, or $3.27 per share, within the prior-year interval.

RenaissanceRe ended the quarter with a e-book worth per share of $250.48 and a tangible e-book worth per share of $233.49. Together with collected dividends, tangible e-book worth per share reached $263.58.

The corporate generated an annualized working return on common frequent fairness of 21.8% and an annualized return on common frequent fairness of 10.5%.

Click on right here to obtain our most up-to-date Positive Evaluation report on RNR (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #8: RELX plc (RELX)

• Consecutive Years Of Dividend Will increase: 27
• Annual Anticipated Returns: 13.4%

RELX is a worldwide supplier of information-based analytics and resolution instruments for skilled and enterprise prospects.

It operates by 4 segments: Scientific, Technical & Medical, and Danger & Enterprise Analytics; Authorized; and Exhibitions.

RELX PLC was integrated in 1903 and is headquartered in London, the UK. It serves prospects in additional than 180 nations, and has places of work in about 40 nations. 

On February twelfth, 2026, RELX PLC reported its outcomes for the 12 months ending December thirty first, 2025. For the interval, adjusted earnings-per-share was 128.5p ($1.52), 10% greater than final 12 months in fixed foreign money phrases.

The rise in EPS was primarily pushed by greater revenues, which grew by 7% on an underlying foundation to £9.6 billion ($11.3 billion), and improved profitability, with the adjusted working margin growing to 34.8%.

The corporate’s largest enterprise phase, Danger, reported income progress of 8%. Scientific, Technical & Medical income grew by 5%, whereas Authorized delivered an extra step up in progress at 9%.

Exhibitions reported underlying income progress of 8%, reflecting continued sturdy demand throughout its occasion portfolio. 

Click on right here to obtain our most up-to-date Positive Evaluation report on RELX (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #7: Medtronic plc (MDT)

• Consecutive Years Of Dividend Will increase: 47
• Annual Anticipated Returns: 13.7%

Medtronic is the most important producer of biomedical gadgets and implantable applied sciences on the earth.

It serves physicians, hospitals, and sufferers in additional than 150 nations and has over 95,000 workers. Medtronic has 4 working segments: Cardiovascular, Medical Surgical, Neuroscience and Diabetes.

The corporate generated $34 billion in income in its final fiscal 12 months.

In mid-February, Medtronic reported (2/17/26) outcomes for the third quarter of fiscal 2026. Natural income grew 6% over the prior 12 months’s quarter because of sturdy progress in Cardiovascular and Diabetes.

Resulting from elevated promoting and administrative bills, earnings-per-share dipped -2%, from $1.39 to $1.36, however exceeded the analysts’ consensus by $0.05.

As well as, Medtronic reiterated its steerage for five.5% progress of natural income and earnings-per-share of $5.62-$5.66 in fiscal 2026.

Medtronic has raised its dividend for 47 consecutive years. It has grown its dividend by 9.7% per 12 months on common over the past decade and by 5.6% per 12 months on common over the past 5 years.

Click on right here to obtain our most up-to-date Positive Evaluation report on MDT (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #6: Pentair plc (PNR)

• Consecutive Years Of Dividend Will increase: 50
• Annual Anticipated Returns: 14.3%

Pentair plc is a pure-play water options firm that operates in 3 segments: Aquatic Programs, Filtration Options, and Movement Applied sciences.

Pentair was based in 1966. Pentair has elevated its dividend for nearly 5 many years in a row, when adjusted for spin-offs, which makes Pentair a member of the Dividend Aristocrat.

Pentair reported its fourth quarter earnings outcomes on February 3. The corporate generated revenues of $1.02 billion in the course of the quarter, which was up 5% in comparison with the corporate’s revenues in the course of the earlier 12 months’s quarter, a consequence that beat estimates barely, by $10 million.

Core gross sales, which exclude the influence of foreign money fee actions, acquisitions, and dispossessions, had been up 4% 12 months over 12 months as effectively, which was higher than the core income progress fee in the course of the earlier quarter.

Pentair recorded adjusted earnings-per-share of $1.18 for the fourth quarter, which was up by 9% year-over-year. Pentair’s earnings-per-share beat the analyst consensus by $0.02.

For fiscal 2026, Pentair is forecasting earnings-per-share of round $5.33, which signifies a considerable revenue enhance versus 2025, throughout which Pentair had earned $4.92 on a per-share foundation.

Click on right here to obtain our most up-to-date Positive Evaluation report on PNR (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #5: Fresenius Medical Care AG (FMS)

• Consecutive Years Of Dividend Will increase: 26
• Annual Anticipated Returns: 14.4%

Fresenius Medical Care AG is a diversified healthcare company centered on services associated to renal illnesses.

The corporate’s companies embrace kidney dialysis, medical laboratory testing, and kidney diagnostic procedures. Fresenius Medical is headquartered in Germany.

On February twenty fourth, 2026, Fresenius Medical launched fourth quarter and full 12 months outcomes. For the quarter, income grew 11.7% to just about $6 billion whereas earnings-per-share totaled $0.85. Each figures had been forward of estimates.

For the 12 months, income grew 5% at fixed foreign money whereas adjusted EPS of $2.49 in comparison with $1.66 in 2024. Natural income grew 8% for the quarter and full 12 months.

Quarterly income for Care Supply, previously often known as Well being Care Providers, grew 7% organically. The U.S. enterprise was up 9% as favorable fee and payor combine results, reimbursement laws, and a constructive influence from diminished implicit value concessions, partially offset by divestitures.

The worldwide enterprise grew 4% as similar market remedies had been up 1.7%. Worth-Based mostly Care income surged 42% due as soon as once more to greater member months.

As of the tip of the quarter, Fresenius Medical had 291,902 sufferers and three,601 clinics worldwide in comparison with 293,620 sufferers and three,628 clinics in Q3 2025.

The corporate expects working revenue to develop by 3% to 7% by 2028. Fresenius Medical is anticipated to earn $2.96 per share in 2026.

Click on right here to obtain our most up-to-date Positive Evaluation report on FMS (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #4: Sanofi (SNY)

• Consecutive Years Of Dividend Will increase: 31
• Annual Anticipated Returns: 15.9%

Sanofi is a worldwide pharmaceutical chief that develops quite a lot of therapeutic remedies and vaccines.

Prescription drugs account for almost all of gross sales, with vaccines making up the rest. Sanofi produces annual revenues of about $51 billion.

Sanofi is integrated in France, however U.S. buyers have entry to the corporate by an American Depositary Receipt, or ADR. Two ADR shares equal one share of the underlying firm.

On January twenty ninth, 2026, Sanofi introduced fourth quarter and full 12 months outcomes. Until in any other case famous, all figures are listed in U.S. {dollars} and at fixed change charges.

For the quarter, income grew 23% to $13.5 billion, which topped estimates by $235 million. The corporate’s earnings-per-share per ADR of $0.91 in contrast favorably to $0.68 within the prior 12 months and was $0.06 greater than anticipated.

For the 12 months, income grew 4.8% to $50.7 billion whereas earnings-per-share per ADR of $4.53 in comparison with 4.11 in 2024.

Dupixent, which treats sufferers with moderate-to-severe bronchial asthma, had income progress of 32.2% in the course of the interval resulting from further launches and good points throughout indications and geographies.

Sanofi has 80 merchandise in improvement, with as many as 40 new potential new medicines and vaccines.

Sanofi offered an outlook for 2026 as effectively. The corporate expects income to develop at a excessive single-digit proportion with EPS growing at a barely greater fee.

Click on right here to obtain our most up-to-date Positive Evaluation report on SNY (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #3: Novo Nordisk (NVO)

• Consecutive Years Of Dividend Will increase: 29
• Annual Anticipated Returns: 18.0%

Novo Nordisk A/S ADR is a big international pharmaceutical firm headquartered in Denmark. The corporate focuses on two core enterprise segments: Diabetes & Weight problems Care and Uncommon Ailments.

The Diabetes & Weight problems Care phase manufactures insulin, associated supply techniques, oral anti-diabetic merchandise, and merchandise to deal with weight problems.

The Uncommon Ailments phase manufactures merchandise for hemophilia and different persistent illnesses. Novo Nordisk derives ~92% of income from diabetes and weight problems.

The corporate’s merchandise are marketed in 170 nations however roughly 48% of web gross sales are from North America and the remainder is worldwide gross sales.1 Whole income was practically $49.11B in 2025.

Novo Nordisk reported This fall 2025 outcomes on February third, 2026. Firm-wide gross sales had been up 6% in Danish kroner and diluted earnings per share rose 2% to 23.03 DKK ($3.66) from 22.63 DKK ($3.60) on a year-over-year foundation.

Diabetes & Weight problems gross sales elevated 7% to 289,456M DKK ($45,993M) pushed by will increase in Ozempic and Wegovy (weight problems), offset by decrease gross sales for Rybelsus (GLP-1), human insulin, long-acting insulin, fast-acting insulin, Saxenda (weight problems), Victoza (GLP-1), and premix insulin.

The Uncommon Illness phase gross sales rose 5% to 19,608M DKK ($3,116M) brought on by rising uncommon problems medication, offset by decrease uncommon blood dysfunction medication.

Click on right here to obtain our most up-to-date Positive Evaluation report on NVO (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #2: Amcor plc (AMCR)

• Consecutive Years Of Dividend Will increase: 42
• Annual Anticipated Returns: 20.0%

Amcor plc is among the world’s most outstanding designers and producers of packaging for meals, pharmaceutical, medical, and different shopper merchandise.

Amcor reported its second quarter outcomes for Fiscal Yr 2026 on February third, 2026. The corporate reported sturdy fiscal Q2 2026 outcomes, with web gross sales of $5.45 billion, up 68% year-over-year, largely pushed by the Berry International acquisition.

Adjusted profitability improved considerably, with adjusted EBITDA rising 83% to $826 million and adjusted EBIT growing 66% to $603 million, whereas adjusted EPS grew 7% to $0.86.

GAAP web revenue was $177 million ($0.38 per share) resulting from acquisition-related prices, and free money circulate totaled $289 million after roughly $69 million in integration and restructuring bills.

For the primary half of fiscal 2026, web gross sales reached $11.19 billion, up 70% year-over-year, reflecting $4.5 billion of acquired gross sales from the Berry mixture.

Amcor reaffirmed its fiscal 2026 steerage, anticipating adjusted EPS of $4.00–$4.15, representing 12–17% fixed foreign money progress in contrast with fiscal 2025.

The corporate additionally expects free money circulate of $1.8–$1.9 billion, supported by at the least $260 million in pre-tax synergy advantages from the Berry acquisition.

Click on right here to obtain our most up-to-date Positive Evaluation report on AMCR (preview of web page 1 of three proven under):

Worldwide Dividend Aristocrat #1: Thomson-Reuters (TRI)

• Consecutive Years Of Dividend Will increase: 33
• Annual Anticipated Returns: 25.0%

Thomson Reuters Company is a worldwide monetary info and information options supplier for companies and professionals within the fields of finance, accounting, tax, and media.

In January 2025, Thomson acquired cPaperless, LLC (SafeSend) for $600 million money, for its tax automation capabilities.

In February 2026, Thomson Reuters introduced a ten% enhance to the dividend to $2.62 per share, which marked the thirty third consecutive annual dividend enhance.

Thomson Reuters reported fourth quarter 2025 outcomes on February fifth, 2026. For the quarter, whole firm income grew 5% year-over-year to $2.01 billion, of which the bulk (84%) was recurring revenues.

Thomson Reuters produced adjusted EPS of $1.07 per share in comparison with adjusted EPS of $1.01 in This fall 2024.

For 2026, Thomson Reuters forecasts whole income progress of seven.5% to eight.0%, adjusted EBITDA margin progress of 100 foundation factors, and free money circulate of $2.1 billion.

Click on right here to obtain our most up-to-date Positive Evaluation report on TRI (preview of web page 1 of three proven under):

Further Studying

The next Positive Dividend databases comprise probably the most dependable dividend growers in our funding universe:

• Dividend Champions: 25+ years of rising dividends
• Dividend Kings: thought of to be the last word dividend progress shares, the Dividend Kings record is comprised of shares with 50+ years of consecutive dividend will increase

In the event you’re searching for shares with distinctive dividend traits, think about the next Positive Dividend databases: